These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 12424539

  • 1. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L, Lalle M, Pandolfi A, Ruscio C, Amodeo R.
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [Abstract] [Full Text] [Related]

  • 2. High-dose therapy supported with immunomagnetic purged autologous bone marrow in high-grade B cell non-Hodgkin's lymphoma.
    Blystad A, Kvalheim G, Torlakovic E, Holte H, Jacobsen E, Beiske K, Vâlerhaugen H, Lenschow E, Kvaloy S.
    Bone Marrow Transplant; 1999 Oct; 24(8):865-72. PubMed ID: 10516698
    [Abstract] [Full Text] [Related]

  • 3. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
    van Heeckeren WJ, Vollweiler J, Fu P, Cooper BW, Meyerson H, Lazarus HM, Simic A, Laughlin MJ, Gerson SL, Koç ON.
    Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019
    [Abstract] [Full Text] [Related]

  • 4. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    Bierman PJ, Sweetenham JW, Loberiza FR, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation.
    J Clin Oncol; 2003 Oct 15; 21(20):3744-53. PubMed ID: 12963703
    [Abstract] [Full Text] [Related]

  • 5. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J, Fauth F, Keyser M, Petershofen E, Weber C, Lippok G, Hoelzer D, Martin H.
    Bone Marrow Transplant; 2000 Jan 15; 25(1):97-104. PubMed ID: 10654022
    [Abstract] [Full Text] [Related]

  • 6. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
    Flohr T, Hess G, Kolbe K, Gamm H, Nolte H, Stanislawski T, Huber C, Derigs HG.
    Bone Marrow Transplant; 2002 May 15; 29(9):769-75. PubMed ID: 12040475
    [Abstract] [Full Text] [Related]

  • 7. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
    Grañena A, Castellsagué X, Badell I, Ferra C, Ortega J, Brunet S, Puntí C, Sureda A, Picón M, Valls A, Rutllant M, García J.
    Bone Marrow Transplant; 1999 Sep 15; 24(6):621-7. PubMed ID: 10490727
    [Abstract] [Full Text] [Related]

  • 8. Autologous bone marrow transplantation for progressive non-Hodgkin's lymphoma: clinical impact of immunophenotype and in vitro purging.
    Weisdorf DJ, Haake R, Miller WJ, McGlave PB, LeBien TW, Vallera DA, Lasky LC, Kim TH, Peterson BA, Ramsay NK.
    Bone Marrow Transplant; 1991 Aug 15; 8(2):135-42. PubMed ID: 1933055
    [Abstract] [Full Text] [Related]

  • 9. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
    Bird JM, Luger S, Mangan P, Edelstein M, Silberstein L, Powlis W, Ball J, Schultz DJ, Stadtmauer EA.
    Bone Marrow Transplant; 1996 Aug 15; 18(2):309-13. PubMed ID: 8864439
    [Abstract] [Full Text] [Related]

  • 10. Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
    Stockerl-Goldstein KE, Horning SJ, Negrin RS, Chao NJ, Hu WW, Long GD, Hoppe RT, Amylon MD, Brown BW, Wong RM, Blume KG.
    Biol Blood Marrow Transplant; 1996 May 15; 2(2):76-85. PubMed ID: 9118302
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
    Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW.
    Biol Blood Marrow Transplant; 2006 Sep 15; 12(9):965-72. PubMed ID: 16920563
    [Abstract] [Full Text] [Related]

  • 12. [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
    Hirose A, Yamane T, Nakajima Y, Manabe M, Kanashima H, Hagihara K, Sakamoto E, Nakamae M, Terada Y, Kosaka S, Aoyama Y, Sakamoto C, Kumura T, Koh KR, Hirai M, Ohta K, Nakao Y, Mugitani A, Teshima H, Hino M.
    Gan To Kagaku Ryoho; 2005 Dec 15; 32(13):2059-64. PubMed ID: 16352929
    [Abstract] [Full Text] [Related]

  • 13. Autologous stem cell transplantation (ASCT) with immunologically purged progenitor cells in patients with advanced stage follicular lymphoma after early partial or complete remission: toxicity, follow-up of minimal residual disease and survival.
    González-Barca E, Fernández de Sevilla A, Domingo-Claros A, Romagosa V, Martín-Henao GA, De Sanjose S, Carmona M, Petit J, García J, Grañena A.
    Bone Marrow Transplant; 2000 Nov 15; 26(10):1051-6. PubMed ID: 11108302
    [Abstract] [Full Text] [Related]

  • 14. [Bone marrow autotransplantation in acute myeloblastic leukemia in its first complete remission. The clinical results in 41 patients].
    Tomás JF, Gómez-García de Soria V, Pinilla I, Lamana M, Figuera A, Arranz R, Cámara R, Fernández-Villalta MJ, Alegre A, Fernández-Rañada JM.
    Med Clin (Barc); 1997 Feb 15; 108(6):201-6. PubMed ID: 9102484
    [Abstract] [Full Text] [Related]

  • 15. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ.
    Biol Blood Marrow Transplant; 2007 Apr 15; 13(4):486-92. PubMed ID: 17382255
    [Abstract] [Full Text] [Related]

  • 16. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
    Wójcik B, Kowalczyk JR, Chybicka A, Wachowiak J, Drabko K, Zaucha-Prazmo A, Choma M, Gorczyńska E, Toporski J, Turkiewicz D, Kałwak K, Pieczonka A, Boruczkowski D.
    Przegl Lek; 2004 Apr 15; 61 Suppl 2():53-6. PubMed ID: 15686047
    [Abstract] [Full Text] [Related]

  • 17. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
    Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
    Bone Marrow Transplant; 2002 Dec 15; 30(12):885-91. PubMed ID: 12476281
    [Abstract] [Full Text] [Related]

  • 18. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED, Wilson J, Phelps V, Neudorf S.
    Bone Marrow Transplant; 2000 Apr 15; 25(8):823-9. PubMed ID: 10808202
    [Abstract] [Full Text] [Related]

  • 19. PCR detection of residual Bcl-2/IgH-positive cells after high-dose therapy with autologous stem cell transplantation is a prognostic factor for event-free survival in patients with low-grade follicular non-Hodgkin's lymphoma.
    Mahé B, Milpied N, Mellerin MP, Moreau P, Morineau N, Vigier M, Harousseau JL.
    Bone Marrow Transplant; 2003 Mar 15; 31(6):467-73. PubMed ID: 12665842
    [Abstract] [Full Text] [Related]

  • 20. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
    Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A, Sureda A, Zuazu J, Marin J, Arranz R, Carreras E, Leon A, De Sevilla AF, San Miguel JF, Conde E, GEL/TAMO Spanish Group.
    Haematologica; 2003 Dec 15; 88(12):1372-7. PubMed ID: 14687990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.